Potential Disease-Modifying Effects of Lithium Carbonate in Niemann-Pick Disease, Type C1
Conclusion: Lithium is a potential therapeutic option for NP-C1 patients. Larger randomized and double-blind clinical trials are needed to further support this finding.Clinical Trial Registration:ClinicalTrials.gov, NCT03201627.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Bipolar | Brain | Clinical Trials | Drugs & Pharmacology | Lithium | Lithium Carbonate | Mania | Neurology | Niemann-Pick Disease | Stroke | Study | USA Health